These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 22212889

  • 1. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
    Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Higuchi R, Kawano Y, Yokota S, Sugiyama N, Yuasa H, Fletcher T, Wajdula JS.
    Mod Rheumatol; 2012 Sep; 22(5):720-6. PubMed ID: 22212889
    [Abstract] [Full Text] [Related]

  • 2. Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
    Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Kurosawa R, Kawano Y, Yokota S, Sugiyama N, Yuasa H, Fletcher T, Wajdula JS.
    Mod Rheumatol; 2011 Dec; 21(6):572-8. PubMed ID: 21479889
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.
    Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2006 Jun; 54(6):1987-94. PubMed ID: 16732547
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, Schmeling H, German and Austrian Paediatric Rheumatology Collaborative Study Group.
    Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
    [Abstract] [Full Text] [Related]

  • 5. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
    Nerome Y, Imanaka H, Nonaka Y, Takei S.
    Mod Rheumatol; 2007 Apr; 17(6):526-8. PubMed ID: 18084710
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.
    Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kümmerle-Deschner JB, Tenbrock K, Ganser G, Huppertz HI.
    Arthritis Rheumatol; 2015 May; 67(8):2240-9. PubMed ID: 25891010
    [Abstract] [Full Text] [Related]

  • 7. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    Drugs; 2002 May; 62(17):2493-537. PubMed ID: 12421111
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
    Horneff G, Ebert A, Fitter S, Minden K, Foeldvari I, Kümmerle-Deschner J, Thon A, Girschick HJ, Weller F, Huppertz HI.
    Rheumatology (Oxford); 2009 Aug; 48(8):916-9. PubMed ID: 19483091
    [Abstract] [Full Text] [Related]

  • 9. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.
    Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, Higgins G, Gottlieb B, Singer NG, Chon Y, Lin SL, Baumgartner SW, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2009 Sep; 60(9):2794-804. PubMed ID: 19714630
    [Abstract] [Full Text] [Related]

  • 10. Etanercept in methotrexate-resistant JIA-related uveitis.
    Saeed MU, Raza SH, Goyal S, Cleary G, Newman WD, Chandna A.
    Semin Ophthalmol; 2014 Jan; 29(1):1-3. PubMed ID: 24175644
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study.
    Schmeling H, Mathony K, John V, Keysser G, Burdach S, Horneff G.
    Ann Rheum Dis; 2001 Apr; 60(4):410-2. PubMed ID: 11247875
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.
    Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ, Childhood Arthritis and Rheumatology Research Alliance (CARRA).
    J Rheumatol; 2014 Jun; 41(6):1163-70. PubMed ID: 24786928
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
    Otten MH, Prince FH, Armbrust W, ten Cate R, Hoppenreijs EP, Twilt M, Koopman-Keemink Y, Gorter SL, Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW.
    JAMA; 2011 Dec 07; 306(21):2340-7. PubMed ID: 22056397
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study.
    Lahdenne P, Vähäsalo P, Honkanen V.
    Ann Rheum Dis; 2003 Mar 07; 62(3):245-7. PubMed ID: 12594111
    [Abstract] [Full Text] [Related]

  • 18. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.
    Prince FH, Geerdink LM, Borsboom GJ, Twilt M, van Rossum MA, Hoppenreijs EP, Cate RT, Koopman-Keemink Y, van Santen-Hoeufft M, Raat H, van Suijlekom-Smit LW.
    Ann Rheum Dis; 2010 Jan 07; 69(1):138-42. PubMed ID: 19581280
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
    Aikawa NE, França IL, Ribeiro AC, Sallum AM, Bonfa E, Silva CA.
    Vaccine; 2015 Jan 29; 33(5):604-9. PubMed ID: 25554240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.